Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay.
Saved in:
| Title: | Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay. |
|---|---|
| Authors: | Irsara, Christian1 (AUTHOR), Egger, Alexander E.1 (AUTHOR), Prokop, Wolfgang1 (AUTHOR), Nairz, Manfred2 (AUTHOR), Loacker, Lorin1 (AUTHOR), Sahanic, Sabina2 (AUTHOR), Pizzini, Alex2 (AUTHOR), Sonnweber, Thomas2 (AUTHOR), Mayer, Wolfgang3 (AUTHOR), Schennach, Harald3 (AUTHOR), Loeffler-Ragg, Judith2 (AUTHOR), Bellmann-Weiler, Rosa2 (AUTHOR), Tancevski, Ivan2 (AUTHOR), Weiss, Günter2 (AUTHOR), Anliker, Markus1 (AUTHOR), Griesmacher, Andrea1 (AUTHOR), Hoermann, Gregor1,4 (AUTHOR) gregor.hoermann@tirol-kliniken.at |
| Source: | Clinical Chemistry & Laboratory Medicine. 2021, Vol. 59 Issue 6, p1143-1154. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14346621 |
|---|---|
| DOI: | 10.1515/cclm-2020-1758 |